Biological Valves in Younger Patients Undergoing Aortic Valve Replacement: A Word of Caution.
From Sheffield Teaching Hospitals NHS Trust, University of Sheffield, and South Yorkshire Cardiothoracic Centre, Northern General Hospital, Sheffield, UK (N.B.); and Guy's and St Thomas Hospitals, London, UK (J.B.C.). norman.briffa@sth.nhs.uk.
Norman
N
Briffa
From Sheffield Teaching Hospitals NHS Trust, University of Sheffield, and South Yorkshire Cardiothoracic Centre, Northern General Hospital, Sheffield, UK (N.B.); and Guy's and St Thomas Hospitals, London, UK (J.B.C.).
John B
JB
Chambers
D000284:Administration, Oral; D017668:Age of Onset; D000925:Anticoagulants / Q000008:administration & dosage; D001024:Aortic Valve Stenosis / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000601:surgery*; D001705:Bioprosthesis; D005260:Female; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011474:Prosthesis Design; D011475:Prosthesis Failure; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D013997:Time Factors; D065467:Transcatheter Aortic Valve Replacement / Q000009:adverse effects / Q000295:instrumentation*; D016896:Treatment Outcome
D000925:Anticoagulants
aortic valve; aortic valve stenosis; heart valves